Monthly Archives: September 2017

Not Just Humans – Elderly Chimpanzees May Get Alzheimer’s Disease

[ad_1] A recently published study in Science determines whether it is possible for chimpanzees to develop Alzheimer ’s disease as they age. Alzheimer’s disease is a type of dementia that causes problems with cognition, behaviour, and memory. Alzheimer’s is a progressive, debilitating disease with no cure. The full diagnosis occurs when dementia is accompanied by…

Infant Feeding Methods and Future Obesity Risk

[ad_1] A novel study published in the American Journal of Clinical Nutrition investigated the plausible relationships between infant feeding methods (breastfeeding and formula feeding), patterns of growth, and future obesity risk from 0-7 months of age. Prior research studies have established that a high body mass index (BMI) and increased rate of weight gain during…

Abiraterone Improves Survival Rate of Prostate Cancer Patients

[ad_1] Recent clinical trials have provided evidence that treating metastatic prostate cancer with a combination of abiraterone and androgen-depravation therapy (ADT) significantly improves the survival rate of patients with metastatic or locally advanced prostate cancer. Approximately one in seven men worldwide are diagnosed with prostate cancer at least once in their life, and so ensuring…

Fasting Plasma Glucose and Fasting Insulin: Biomarkers of Diet Success

[ad_1] A recent study assesses the success of various diets in terms of weight loss and weight maintenance by using fasting insulin and fasting plasma glucose as markers. Obesity is a global epidemic prevalent in most developed countries. Over the years, many diet and exercise regimes have been designed to tackle obesity. Despite numerous variations…

Current Clinical Management of Acute Kidney Injury

[ad_1] Acute kidney injury is a common condition seen by clinicians in different settings. An article published in the Clinical Kidney Journal this 2017 provided an overview of the current diagnosis and clinical management of this condition. An article published in the Clinical Kidney Journal this 2017 provided an overview of the current diagnostic methods…

Improving Traumatic Brain Injury Treatment with Diagnostic Biomarkers

[ad_1] Each year, at least 3.5 million Americans seek medical attention for traumatic brain injury (TBI). Unfortunately, the development of therapies is limited by the absence of accurate biomarkers to improve the diagnosis and classification of TBIs. Biomarkers for Disease A biomarker is a biological substance that can be measured and used as an indicator…

Are Tamoxifen and Exemestane Effective for Reducing Breast Cancer Recurrence?

[ad_1] Over 50 years ago scientists accidentally discovered tamoxifen, the standard adjuvant treatment used for the past three decades to reduce the risk of recurrence in breast cancer patients. However, with advances in research comes new therapeutics and the question arises whether tamoxifen is still the best drug available to help reduce breast cancer recurrence?…

Gene Variants in Early Onset Alzheimer’s Disease

[ad_1] In a 2017 study, researchers examined the relationship between rare gene variants and early-onset Alzheimer’s disease risk. Variants in a number of genes were identified, including PSD2, TCIRG1, and RIN3 – genes important to endolysosomal function. Mutations in a number of key genes have been implicated in the development of 5-10% of early-onset Alzheimer’s…

A Malignant Mesothelioma Treatment Shows No Clinical Benefits

[ad_1] A phase 2b clinical trial testing the efficacy of the anticancer drug tremelimumab for the treatment of relapsed malignant mesothelioma found that the drug may be ineffective in treating the disease. Malignant mesothelioma is a rare and aggressive cancer of the pleural (found in the lung) or peritoneal (found in the abdomen)or pericardial (found…